CYCLERION THERAPEUTICS INC's ticker is CYCN and the CUSIP is 23255M105. A total of 70 filers reported holding CYCLERION THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.33 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $316 | +1655.6% | 727 | +2592.6% | 0.00% | – |
| Q4 2022 | $18 | – | 27 | 0.0% | 0.00% | – |
| Q3 2022 | $0 | – | 27 | 0.0% | 0.00% | – |
| Q2 2022 | $0 | – | 27 | -78.7% | 0.00% | – |
| Q1 2022 | $0 | – | 127 | 0.0% | 0.00% | – |
| Q4 2021 | $0 | – | 127 | 0.0% | 0.00% | – |
| Q3 2021 | $0 | – | 127 | 0.0% | 0.00% | – |
| Q2 2021 | $0 | – | 127 | 0.0% | 0.00% | – |
| Q1 2021 | $0 | – | 127 | 0.0% | 0.00% | – |
| Q4 2020 | $0 | -100.0% | 127 | 0.0% | 0.00% | – |
| Q3 2020 | $1,000 | 0.0% | 127 | 0.0% | 0.00% | – |
| Q2 2020 | $1,000 | – | 127 | 0.0% | 0.00% | – |
| Q1 2020 | $0 | – | 127 | 0.0% | 0.00% | – |
| Q4 2019 | $0 | -100.0% | 127 | 0.0% | 0.00% | – |
| Q3 2019 | $2,000 | +100.0% | 127 | 0.0% | 0.00% | – |
| Q2 2019 | $1,000 | – | 127 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MFN Partners Management, LP | 1,487,874 | $17,036,000 | 2.70% |
| BRIDGER MANAGEMENT, LLC | 1,032,633 | $11,824,000 | 0.93% |
| EcoR1 Capital, LLC | 776,206 | $8,888,000 | 0.90% |
| Camber Capital Management LP | 1,561,915 | $17,884,000 | 0.83% |
| CVI Holdings, LLC | 157,114 | $1,798,000 | 0.70% |
| Artal Group S.A. | 1,361,584 | $15,590,000 | 0.63% |
| Slate Path Capital LP | 714,018 | $8,176,000 | 0.37% |
| Sarissa Capital Management LP | 250,000 | $2,862,000 | 0.36% |
| AWH Capital, L.P. | 10,107 | $116,000 | 0.17% |
| Broderick Brian C | 32,919 | $377,000 | 0.13% |